These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical aspects of hypersomnias]. Peter JH Internist (Berl); 1984 Sep; 25(9):547-51. PubMed ID: 6386735 [No Abstract] [Full Text] [Related]
5. [Treatment of a hallucinatory state with diurnal hypersomnia using oxolinic acid]. Lhermitte F; Signoret JL; Agid Y; Laffont F; Jouvent R Nouv Presse Med; 1978 Dec; 7(43):3936. PubMed ID: 569844 [No Abstract] [Full Text] [Related]
6. [Diagnosis, etiopathogenesis and treatment of the Kleine-Levin syndrome]. Smolík P; Roth B Cesk Psychiatr; 1986 Apr; 82(2):127-30. PubMed ID: 3460717 [No Abstract] [Full Text] [Related]
7. Treatment of hypersomnolence in myotonic dystrophy with a CNS stimulant. van der Meché FG; Boogaard JM; van den Berg B Muscle Nerve; 1986 May; 9(4):341-4. PubMed ID: 3713739 [TBL] [Abstract][Full Text] [Related]
9. Medications and their effects on sleep. Pagel JF Prim Care; 2005 Jun; 32(2):491-509. PubMed ID: 15935197 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias]. Palmieri G; Perego M; Nazzari M; Casalini F Clin Ter; 1982 Jun; 101(6):603-14. PubMed ID: 7128029 [No Abstract] [Full Text] [Related]
11. Hypersomnic diazepam abstinence syndrome: a case report. Holt RJ; Pérez-Cruet J Bol Asoc Med P R; 1982 Sep; 74(9):262-4. PubMed ID: 6963915 [No Abstract] [Full Text] [Related]
13. [Hypersomnic syndrome in circulatory disorders of the oral portions of the brain stem (clinico-morphologic observations)]. Kozlova EN; Levina GIa; Chaĭkovskaia RP Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1000-6. PubMed ID: 7293593 [TBL] [Abstract][Full Text] [Related]
14. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Noseda G; Fragiacomo C; Weidmann P; Bachmann C Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660 [TBL] [Abstract][Full Text] [Related]
15. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091 [TBL] [Abstract][Full Text] [Related]
16. [Hyperlipoproteinemia in children. Apropos of 6 cases]. Boudhina T; Yedes A; Lakhoua R; Yedes M; Ben Becheur S; Ghram N; Makni S; Hamza M; Jedidi H Tunis Med; 1988 Nov; 66(11):779-82. PubMed ID: 3238780 [No Abstract] [Full Text] [Related]
17. [Algorithms for diagnosis and therapy of sleep disorders in general practice]. Riemann D; Hornyak M; Voderholzer U; Berger M MMW Fortschr Med; 2003 May; 145 Suppl 2():55-60. PubMed ID: 14579486 [TBL] [Abstract][Full Text] [Related]
20. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Jones DE; Newton JL Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]